Risk factors for miscarriage from a prevention perspective: a nationwide follow‐up study

Re: Immediate versus delayed initiation of the levonorgestrel‐releasing intrauterine system following medical termination of pregnancy – 1‐year continuation rates: a randomised controlled trial

“…1,2 Her ideas to improve this study and suggestions of further analyses were interesting; however, this study was a pragmatic one, evaluating the immediate insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) following medical termination of pregnancy (MTOP). The details of care were carried out according to the Finnish national guideline on MTOP.…”

“…1 Pregnancyrelated complications and subsequent adverse outcomes after specific drug dosage(s) are emerging as a major public problem in the field of maternal-fetal medicine globally. 2 The overall quality of the present study was impressive, with well-defined and stringent inclusion and exclusion criteria for the enrollment of eligible subjects during a specific timeline, thereby enhancing the reliability of the findings/data generated by assessment(s) of the main outcomes, viz. LNG-IUS use at 1 year after MTOP amongst a total number of 267 eligible women requesting MTOP and planning LNG-IUS for post-MTOP contraception at Helsinki University Hospital, Finland, from January 2013 to December 2014.…”

“…published in your reputed BJOG journal is indeed enlightening, and provides critical clinical insights into the immediate and/or delayed initiation of the levonorgestrel‐releasing intrauterine system (LNG‐IUS) following medical termination of pregnancy (MTOP) amongst a specific patient population subset ( n = 267 women); the 1‐year continuation rate in this elegantly designed randomised controlled trial has been well documented by following ethical guidelines of good practice research . Pregnancy‐related complications and subsequent adverse outcomes after specific drug dosage(s) are emerging as a major public problem in the field of maternal–fetal medicine globally …”

“…The purpose of our paper 2 was to contribute to the scarce knowledge regarding women's use of antenatal healthcare services and interventions during childbirth in pregnancies subsequent to stillbirth. Hopefully, such knowledge provides a base for future studies aiming to evaluate the effects of care and interventions that currently are or should be provided for this patient group.…”

Re: The impact of a novel transendometrial approach for caesarean myomectomy on obstetric outcomes of subsequent pregnancy: a longitudinal panel study

“…published in the reputed BJOG journal provides critical clinical insights in the utilisation of novel transendometrial regimen for caesarean myomectomy on obstetric outcomes of subsequent pregnancy in a specific population subset (pregnant women complicated with uterine myoma) . Pregnancy‐related disorders, including obstetrics/surgical adverse outcomes especially during caesarean section(s), are emerging as major causes of maternal morbidity and mortality globally; recent years have witnessed an increasing trend of stillbirths, postpartum haemorrhage, miscarriages, fetal anomalies, endometriosis, uterine rupture and myoma among reproductive‐aged women worldwide of varying socio‐cultural backgrounds and genetic diversities …”